|
|
Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Interim results from the defifrance study
Mohamad Mohty
,
Myriam Labopin
,
Delphine Lebon
,
Ana Berceanu
,
Charlotte Jubert
,
et al.
Bone Marrow Transplantation, 2019, 54 (1), pp.231-232
Article dans une revue
hal-03606394v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma
Anais Schavgoulidze
,
Valérie Lauwers-Cances
,
Aurore Perrot
,
Titouan Cazaubiel
,
Marie-Lorraine Chretien
,
et al.
Article dans une revue
hal-03801805v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)
Ramy Rahme
,
Lionel Ades
,
Xavier Thomas
,
Agnes Guerci-Bresler
,
Arnaud Pigneux
,
et al.
Article dans une revue
hal-03605023v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features
Titouan Cazaubiel
,
Xavier Leleu
,
Aurore Perrot
,
Salomon Manier
,
Laure Buisson
,
et al.
Article dans une revue
hal-03684088v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French network
Laurence Schenone
,
Caroline Houillier
,
Marie Laure Tanguy
,
Sylvain Choquet
,
Kossi Agbetiafa
,
et al.
Article dans une revue
hal-03703797v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study
Mohamad Mohty
,
Didier Blaise
,
Régis Peffault de Latour
,
Myriam Labopin
,
Jean Henri Bourhis
,
et al.
Article dans une revue
hal-03915550v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Twice Weekly Induction with Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination Followed By Extended IRD Consolidation and Lenalidomide Maintenance in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du Myelome (IFM 2014-03)
Murielle Roussel
,
Benjamin Hebraud
,
Cyrille Hulin
,
Xavier Leleu
,
Thierry Facon
,
et al.
Article dans une revue
hal-03605012v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau
,
Michel Attal
,
Cyrille Hulin
,
Bertrand Arnulf
,
Karim Belhadj
,
et al.
Article dans une revue
hal-03605015v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|